MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the
issuance of secured...
$125,000K
Impairment of goodwill and
long-lived assets
$319,400K
Proceeds from revolving
credit facility
$40,000K
Proceeds from common
stock issued under...
$3,300K
Depreciation and
amortization
$53,700K
Stock-based compensation
expense
$35,200K
Non-cash lease expense
$7,700K
Trade accounts
receivable
-$6,200K
Prepaid taxes
-$4,400K
Other non-cash
adjustments
$3,400K
Other assets
-$2,000K
Prepaid expenses and
other current assets
-$200K
Deferred income taxes
$100K
Net cash provided by
(used in) financing...
$64,200K
Net cash provided by
(used in) operating...
$1,800K
Effect of foreign
exchange rates on cash,...
$800K
Canceled cashflow
$104,100K
Canceled cashflow
$430,500K
Net increase
(decrease) in cash, cash...
$39,400K
Canceled cashflow
$27,400K
Repayment of revolving
credit facility
$80,500K
Fees associated with
issuance of secured...
$8,600K
Release of cash held in
escrow
$7,500K
Payment of tax withheld
for common stock...
$7,300K
Other financing
activities
-$200K
Net loss
-$365,900K
Unrecognized tax benefits
$32,500K
Accrued liabilities
-$27,500K
Inventory
$3,200K
Accounts payable
-$1,400K
Net cash (used in)
provided by investing...
-$27,400K
Capital expenditures
$15,600K
Capitalization of intangible
assets
$11,800K
Back
Back
Cash Flow
source: myfinsight.com
MYRIAD GENETICS INC (MYGN)
MYRIAD GENETICS INC (MYGN)